Rai, Rajeev;
Naseem, Asma;
Vetharoy, Winston;
Steinberg, Zohar;
Thrasher, Adrian J;
Santilli, Giorgia;
Cavazza, Alessia;
(2023)
An improved medium formulation for efficient ex vivo gene editing, expansion and engraftment of hematopoietic stem and progenitor cell populations.
Molecular Therapy - Methods and Clinical Development
, 29
pp. 58-69.
10.1016/j.omtm.2023.02.014.
Preview |
Text
1-s2.0-S2329050123000244-main.pdf Download (2MB) | Preview |
Abstract
Gene editing has emerged as a powerful tool for the therapeutic correction of monogenic diseases. CRISPR/Cas9 applied to hematopoietic stem and progenitor cells (HSPCs) has shown great promise in proof-of-principle preclinical studies to treat hematological disorders, and clinical trials using these tools are now underway. Nonetheless, there remain important challenges that need to be addressed, such as the efficiency of targeting primitive, long-term repopulating HSPCs and their in vitro expansion for clinical application. In this study, we assessed the effect of different culture medium compositions on the ability of HSPCs to proliferate and undergo homology directed repair-mediated knock-in of a reporter gene, while preserving their stemness features during ex vivo culture. We demonstrated that by supplementing the culture medium with stem cell agonists and by fine-tuning its cytokine composition it is possible to achieve high levels of gene targeting in long-term repopulating HSPCs both in vitro and in vivo, with a beneficial balance between preservation of stemness and cell expansion. Overall, the implementation of this optimized ex vivo HSPC culture protocol can improve the efficacy, feasibility and applicability of gene editing as a key step to unlocking the full therapeutic potential of this powerful technology.
Archive Staff Only
 |
View Item |
